|
Bestrahlungsfolgen 40 Arzneien acet-ac. aloe. arist-cl. ars. ars-br. bell. gano-t. cadm-i. cadm-met. cadm-s. calen. camph. calc-f. carb-ac. canth. caust. cit-ac. cob-n. con. epil-a. fl-ac. ign. ip. kali-bi. kreos. lach. mag-p. nux-v. phos. pic-ac. plut-met. psor. rad-br. rhus-t. sil. sol. stront-c. sulph. urt-u. x-ray. keine Fälle=ein- >1-2 Fälle=zwei- >2 Fälle=Drei- >5 Fälle=Vier- >10 Fälle=FÜNF-wertig ()=BegleitTherapie *=palliativ **=TeilWirkung ***=1-Jahr ****5-Jahre-Nachbeobachtung wichtig, bzw. verlässlich |
| ^ | acet-ac | lby5 |
| ^ | aloe | =extern, wrj1 |
| ^ | arist-cl | lby5 |
| ^ | ars | lby5 |
| ^ | ars-br | rmk1 |
| ^ | bell | sne |
| ^ | gano-t | sne |
| ^ | cadm-i | =Radium, gm1 |
| ^ | cadm-met | gm |
| ^ | cadm-s | gm, p1 |
| ^ | calen | =extern, Coleman, wrj1 |
| ^ | camph | sne |
| ^ | calc-f | sne |
| ^ | carb-ac | lby5 |
| ^ | canth | sne |
| ^ | caust | wrj1 |
| ^ | cit-ac | sne |
| ^ | cob-n | lby5 |
| ^ | con | sne |
| ^ | epil-a | sne |
| ^ | fl-ac | gm1 |
| ^ | ign | sne |
| ^ | ip | p1 |
| ^ | kali-bi | sne |
| ^ | kreos | wrj1 |
| ^ | lach | wrj1 |
| ^ | mag-p | sne |
| ^ | nux-v | wrj1 |
| ^ | phos | gm1, snd, wrj1 |
| ^ | pic-ac | lby5 |
| ^ | plut-met | Lby5 |
| ^ | psor | sne |
| ^ | rad-br | gm, rmk1, wrj1 |
| ^ | rhus-t | sne |
| ^ | sil | gm, wrj1 |
| ^ | sol | lby5 |
| ^ | stront-c | gm1 |
| ^ | sulph | sne |
| ^ | urt-u | sne |
| ^ | x-ray | gm1, p1, wrj1 |